The problem the researchers set out to solve is one of fragmentation. Liver aging involves several distinct cellular processes that are usually measured in isolation: the ploidy of hepatocytes, meaning how many copies of the genome each liver cell carries; the frequency of binucleated cells, which carry two nuclei; the proliferative activity of the tissue; and the accumulation of senescent cells that have permanently exited the cell cycle. Each of these features tells part of the story, but none of them alone describes the overall regenerative phenotype of the organ. The team’s answer was to combine them into single numerical descriptors that can be tracked over time and compared across experimental groups.

The first of these measures is the Index of Regenerative Reserve, abbreviated IRR. It is defined as the proportion of binucleated hepatocytes divided by the mean hepatocyte ploidy. The logic behind this ratio reflects the biology of the liver. Binucleated hepatocytes are generally associated with a state in which cells have completed cell-cycle events without dividing, and their abundance has been linked to regenerative flexibility. Mean ploidy, meanwhile, rises as hepatocytes undergo repeated rounds of genome duplication without cell division, a process known as polyploidization that becomes more prominent with age and chronic injury. By placing the proportion of binucleated cells over the average ploidy, the index captures the balance between these two faces of hepatocyte cell-cycle adaptation in a single value.

The second measure, the Integrated Index of Regenerative Status, or IRS, builds on the first by adding two molecular markers as fractional terms. The formula is IRS equals IRR multiplied by the quantity one plus Ki-67, divided by the quantity one plus p21. Ki-67 is a well-established marker of active cell proliferation, so a higher value indicates that more hepatocytes are actively cycling. p21 is a cyclin-dependent kinase inhibitor that enforces cell-cycle arrest and is widely used as a marker of cellular senescence. By multiplying the regenerative reserve by a proliferation-weighted numerator and a senescence-weighted denominator, the IRS is designed to fall when proliferative activity wanes or senescent arrest rises, and to hold steady or increase when the tissue retains its capacity to renew.

To test how these indices behave, the researchers turned to a model of accelerated aging that is unusual among liver studies: chronic circadian disruption. Male Wistar rats were assigned to three lighting conditions. A control group experienced normal light-dark cycles. A second group was kept under constant illumination, a condition the authors describe as dark deprivation, abbreviated DD. A third group experienced the same constant illumination but received melatonin at a dose of 10 milligrams per kilogram of body weight, five times weekly. Animals in all groups were assessed at four time points: 6, 12, 18, and 24 months of age, spanning a substantial fraction of the rat lifespan.

The rationale for this design rests on a growing body of evidence that light at night and disrupted circadian rhythms do more than disturb sleep. Previous work has shown that circadian disruption induced by light-at-night exposure can accelerate aging and promote tumorigenesis in rats, and the circadian clock itself has been shown to regulate hepatic polyploidy through the Mkp1-Erk1/2 signaling pathway. Constant illumination effectively deprives animals of the darkness that signals the pineal gland to produce melatonin, a hormone with antioxidant properties and broad influence over circadian physiology. The third group, in which melatonin was replaced exogenously, allowed the team to ask whether restoring the hormone could protect the liver’s regenerative profile.

The results were striking. In the dark-deprived animals, the Index of Regenerative Reserve fell from 2.00 plus or minus 0.42 at 6 months to 0.386 plus or minus 0.19 at 24 months, a decline of roughly eighty percent over the course of the study. The corresponding Integrated Index of Regenerative Status at 24 months was 0.32 plus or minus 0.17. These numbers depict a liver whose regenerative reserve is progressively eroded under conditions of chronic light exposure, consistent with the idea that circadian disruption drives pro-senescent remodeling of hepatic tissue.

In the animals that received melatonin alongside constant illumination, the picture was entirely different. At 24 months, the IRR in this group stood at 2.285 plus or minus 0.41 and the IRS at 2.08 plus or minus 0.16, values comparable to or even slightly above the starting levels seen in younger animals. In other words, exogenous melatonin appeared to preserve the composite regenerative profile of the liver across nearly the entire observation period, despite the animals being exposed to the same light regime as the unprotected group. The authors note that this finding aligns with their earlier work describing chronic light-induced desynchronosis as a model of accelerated metabolic aging in rats and the preventive role of melatonin in that context.

To explore whether the indices could discriminate between groups in a statistically meaningful way, the team performed an exploratory receiver-operating-characteristic analysis, a method borrowed from diagnostic testing that evaluates how well a continuous measure separates two conditions. The analysis yielded areas under the curve of 0.843 for the IRR and 0.905 for the IRS. An area under the curve of 1.0 represents perfect discrimination, while 0.5 represents chance performance, so values in the mid-0.8 to low-0.9 range indicate substantial, though not perfect, separation between the aging profiles of the dark-deprived and melatonin-treated animals. The IRS, which integrates molecular information on top of the structural measures, showed the stronger discriminatory performance.

The authors are careful about what these numbers do and do not establish. They present the IRR and IRS as experimental composite descriptors of the hepatic regenerative phenotype, and they state explicitly that external validation and direct functional regeneration assays are required before broader biological or clinical interpretation. The indices were developed and tested in a single animal model, and the receiver-operating-characteristic analysis was exploratory rather than confirmatory. Still, the approach addresses a real gap. Human studies have shown that hepatocyte expression of the senescence marker p21 is linked to fibrosis and adverse liver-related outcomes in alcohol-related liver disease, and that early liver regeneration after hepatectomy varies with age, yet clinicians lack integrated quantitative tools to gauge regenerative potential. If validated in independent models and eventually in human tissue, composite indices of this kind could offer a way to monitor how aging, circadian disruption, and interventions such as melatonin reshape the liver’s capacity to renew itself, turning a collection of scattered cellular measurements into a single readable signal of regenerative health.

Subject of Research: Quantitative composite indices of liver regenerative potential in a rat model of accelerated aging under circadian disruption and melatonin treatment

Article Title: Quantitative assessment of liver regenerative potential during accelerated aging: regenerative reserve and regenerative status indices

Article References: Areshidze, D. A., Kozlova, M. A., Anurkina, A. I., & Moskalev, A. (2026). Quantitative assessment of liver regenerative potential during accelerated aging: regenerative reserve and regenerative status indices. Biogerontology, 27(6), Article 179. https://doi.org/10.1007/s10522-026-10527-9

Image Credits: AI Generated

DOI: 10.1007/s10522-026-10527-9

Keywords: liver aging, hepatocyte polyploidy, binucleated hepatocytes, cellular senescence, melatonin, circadian disruption, regenerative capacity, Ki-67, p21, Biogerontology, Quantitative, assessment

The clinical stakes are far from abstract. Organ shortages have made older donor livers a routine part of transplantation, and outcomes still track donor age in ways that stubbornly resist prediction. A registry-based analysis of more than 111,000 liver transplants cited in the review found that when older grafts went to younger recipients, five-year graft survival fell to 69.9 percent, compared with 77.8 percent for young-to-old combinations. Grafts from donors over 60 to 70 years fared particularly poorly in high-risk recipients with MELD scores of 35 or above, and in living donation, use of donors aged 50 and older carried a 61 percent increased hazard of graft failure. The paradox that frustrates clinicians is that age alone incompletely predicts post-transplant behavior. Some older livers retain substantial reserve while others collapse under metabolic overload, inflammatory injury or impaired recovery, which is precisely why the authors argue for a biologically grounded, module-based framework rather than another hunt for a single decisive marker.

That framework rests on five interrelated biological modules that emerged from converging multi-omics evidence: lipid stress and metabolic remodeling, diminished oxidative reserve, proteostatic strain, inflammatory sensitization, and reduced recovery capacity. Each module is supported by different layers of molecular data, and each connects back to mitochondria, the organelles that power fatty-acid oxidation, oxidative phosphorylation, redox homeostasis and detoxification in hepatocytes. The logic is that impaired mitochondrial metabolic flexibility, weakened redox buffering, disrupted organelle crosstalk and failing quality-control systems provide the common substrate on which all five disturbances build. Critically, the authors stress that these modules remain partly compensated at baseline. Molecular age-related changes accumulate quietly while histology and standard blood tests look normal, and only become conspicuous when the liver is challenged by metabolic overload, ischemia-reperfusion injury, cold preservation or ex vivo machine perfusion.

The lipid stress module illustrates how the pieces interlock. Multi-omics studies across mouse strains, diets and ages show that age-associated hepatic phenotypes are shaped not just by time but by genotype and diet, with alterations in fatty-acid handling, lipid-droplet distribution, peroxisomal programs and FGF21 and FABP4 signaling narrowing metabolic flexibility even when baseline function appears preserved. One mechanistic study linked senescence-associated 13-hydroxyoctadecadienoic acid, an oxidized lipid mediator, to age-related steatosis by showing that it directly inhibits catalase, a key antioxidant enzyme. That finding stitches lipid stress to the oxidative reserve module: aged rodent and primate livers repeatedly show altered glutathione balance, elevated reactive oxygen and nitrogen species, increased malondialdehyde, mitochondrial DNA damage and changes in catalase, superoxide dismutase and respiratory-chain proteins. In other words, lipid overload and antioxidant decline are not separate problems but two faces of the same mitochondrial vulnerability.

Proteostatic strain adds a third thread. Rodent phosphoproteomic data and primate single-nucleus studies converge on altered chaperone, protein-degradation and endoplasmic reticulum stress pathways, suggesting that the energetic cost of maintaining protein quality rises with age even in hepatocytes that look intact. The review links this to lipid and redox stress through a mechanistic chain: excess mitochondrial calcium and reactive oxygen species increase ER protein-folding demand, while ATP limitation weakens chaperone and degradation capacity, so proteostatic strain may act as a downstream amplifier of metabolic overload rather than an isolated defect. Inflammatory sensitization operates at the multicellular level. Single-cell studies identify altered endothelial, macrophage, neutrophil and hepatocyte programs in aged liver, and challenge models show that IL-1α signaling between liver sinusoidal endothelial cells and hepatocytes, along with Cxcl2-positive macrophage recruitment of neutrophils, can amplify ischemia-reperfusion injury in old livers. Finally, recovery capacity, the ability to restore metabolic, synthetic and structural homeostasis after injury, is compromised by dysregulated Hedgehog signaling, reduced hepatocyte plasticity and extracellular matrix remodeling, meaning two grafts can absorb similar early stress yet diverge sharply in lactate clearance, bile production and survival.

Why does mitochondria sit at the center rather than the periphery of this network? The review describes a feedback architecture in which lipid overload increases mitochondrial calcium loading and ROS generation, which promotes ER stress and inflammatory signaling; the resulting proteostatic and inflammatory burden then consumes energy and limits repair, further impairing mitochondrial quality control and metabolic flexibility in a self-reinforcing loop. This structure generates testable predictions. A liver carrying combined lipid stress and low redox reserve should show a larger stress-induced rise in mitochondrial, ER-stress and inflammatory readouts and a slower recovery trajectory than a liver with only one abnormal module. The authors are careful to note that mitochondrial vulnerability is the interface connecting the modules, not a separate module itself and not a validated measure of biological age, but it offers a unifying hypothesis for why aging livers with identical birthdays and similar biopsies can behave so differently under duress.

Not all evidence carries equal weight, and the review is unusually candid about this. Rodent studies provide most of the mechanistic depth, with large mouse multi-omics datasets and naturally aged models showing distributed remodeling across lipid metabolism, immune signaling, stress-kinase networks and protein-state regulation. Non-human primate data, though limited in scale and often drawn from female animals, strengthen confidence that ER stress, degradation pathways and hepatocyte pro-senescence programs are conserved rather than rodent-specific artifacts. Human baseline evidence remains the weakest layer: transcriptomic signals of aging are entangled with steatosis, fibrosis, metabolic disease and medication history, and matched human tri-omics datasets are scarce. Spatial and single-cell studies add a crucial caveat about anatomy, showing that hepatocytes do not age uniformly across the lobule. Pericentral cells preferentially accumulate large lipid droplets while periportal cells show more prominent mitochondrial and epigenetic disturbance, which means small biopsies or bulk assays can miss biologically important local variation.

This is where transplantation and machine perfusion enter as natural experiments. Procurement, cold preservation, reperfusion and metabolic reactivation impose rapid, defined swings in oxygen availability and energetic demand, converting modest baseline differences into clinically meaningful ones. Hypothermic oxygenated perfusion and normothermic machine perfusion have already proven their clinical value in randomized trials, reducing early allograft dysfunction, biliary strictures and organ discard, but their scientific value here lies in the sampling window they create. During HOPE, early perfusate flavin mononucleotide, a marker of mitochondrial injury, was higher in grafts that developed early allograft dysfunction, and in a 50-graft validation cohort the five-minute value yielded an area under the curve of 0.744 for early allograft dysfunction and 0.890 for one-year mortality. During NMP, serial perfusate transaminases, lactate dehydrogenase, von Willebrand factor and platelet changes associated with early dysfunction, while perfusate IL-6, TNF-α and IL-10 correlated with postoperative bilirubin, intensive-care stay or graft loss, and bile pH, bicarbonate and glucose tracked biliary viability.

The authors insist these signals are promising readouts, not decision rules. No published study has validated a combined panel across perfusion protocols, and none of the fluid-based markers is aging-specific; they reflect donor comorbidity, ischemia, procurement and preservation strategy as well as age-related vulnerability. The module framework is explicitly hypothesis-generating rather than outcome-validated, and the review warns against merging FMN trajectories, cytokine measurements and biliary chemistry from different cohorts into a clinical scoring system without prospective, matrix-matched validation. What the framework does offer is translational logic: tissue biopsies capture pathway state, serial perfusate captures stress and recovery kinetics, bile captures cholangiocyte function, and post-transplant outcomes provide the ultimate clinical anchor. Future priorities include paired tissue-fluid biobanks, attention to circadian timing and pre-analytical handling of metabolites, spatially informed biopsy interpretation, and explicit separation of immediate procurement injury from genuine recovery behavior in sampling schedules.

The bigger picture is a conceptual shift in how aging science approaches one of medicine’s hardest assessment problems. Rather than seeking a molecular birth certificate for the liver, the review proposes mapping which vulnerability modules are active in a given organ and how they will respond to defined stress. Candidate intervention targets, including FGF21 and FABP4 in lipid metabolism, the 13-HODE-catalase axis in antioxidant buffering and Hedgehog signaling in regenerative reserve, remain experimental, and the authors caution that any therapeutic claim requires direct evidence of benefit against clinically meaningful endpoints. But the reframing itself is consequential: if the most stable features of liver aging are process-level changes that become functionally visible under stress, then machine perfusion may be not just a preservation technology but a stress-testing platform, a controlled environment in which the hidden mitochondrial biography of an aging liver can finally be read before it matters.

Subject of Research: Mitochondrial vulnerability and multi-omics biological modules of the aging liver and their translational relevance to transplantation

Article Title: Multi-omics perspectives on mitochondrial vulnerability in the aging liver: biological modules and translational implications

Article References: Chen, H., Lu, W., Wang, K., Fang, R., Lee, S., Chen, S., & Liu, Z. (2026). Multi-omics perspectives on mitochondrial vulnerability in the aging liver: biological modules and translational implications. Frontiers in Cell and Developmental Biology, 14, Article 1954948. https://doi.org/10.3389/fcell.2026.1954948

Image Credits: AI Generated

DOI: 10.3389/fcell.2026.1954948

Keywords: liver aging, mitochondria, multi-omics, machine perfusion, liver transplantation, oxidative stress, proteostasis, inflammation, biomarkers, FGF21, ischemia-reperfusion injury, hepatocytes

The team began by dissecting the chemistry of the roasted tea. Using colorimetric assays and high-performance liquid chromatography, they quantified the major constituents of the extract. Tea polyphenols dominated at roughly 287 milligrams per gram, followed by catechins at about 138 milligrams per gram, with tea polysaccharides, caffeine, and free amino acids rounding out the profile. Among individual catechins measured against authentic standards, EGCG led at 7.959 milligrams per gram, with catechin, catechin gallate, epigallocatechin, and gallic acid also present in appreciable amounts. Roasting, the authors note, does not merely add flavor; it restructures the active compound inventory, creating the material basis for the tea’s antioxidant, anti-inflammatory, and metabolic effects.

To test whether these compounds could counter aging, the researchers turned to a widely used model in which mice receive daily injections of D-galactose, a sugar that accumulates in tissues and drives oxidative stress, inflammation, and senescence-like damage. Male C57BL/6 mice were divided into four groups of ten: a control group receiving saline, a model group receiving D-galactose alone, and two treatment groups receiving D-galactose plus Nongxiang-type Tieguanyin extract by gavage at either 110 or 550 milligrams per kilogram per day for eight weeks. The doses were not arbitrary. The low dose was scaled from the typical daily tea consumption of Chinese adults, roughly five grams of dry leaves, using standard allometric conversion, while the high dose was set fivefold higher to probe dose dependence.

The behavioral results were striking. D-galactose-treated mice showed sharply reduced endurance on a treadmill, covering less distance before reaching exhaustion, and they faltered earlier on a rotating-rod fatigue test. High-dose tea extract reversed both deficits in a concentration-dependent manner. Grip strength, however, was unaffected, suggesting the compound acts on fatigue and metabolic capacity rather than raw muscle power. Metabolic cage measurements added a circadian dimension: D-galactose suppressed the mice’s 24-hour energy expenditure, with the loss concentrated in the dark phase when rodents are normally most active. High-dose Tieguanyin restored dark-phase energy expenditure to near-normal levels, hinting that the tea helps normalize the daily rhythm of metabolism that frays with age.

The liver emerged as the clear beneficiary. The elevated liver-to-body weight ratio caused by D-galactose fell back toward control values after tea treatment, while the heart, lungs, and kidneys showed no significant changes, indicating a liver-targeted effect. Serum levels of alanine aminotransferase and aspartate aminotransferase, the classic enzymes that spill into blood when hepatocytes are damaged, dropped in treated animals. Inside the liver, the chemical picture shifted just as decisively: levels of the antioxidant enzymes superoxide dismutase and glutathione, depleted by D-galactose, rebounded, while malondialdehyde, a marker of lipid peroxidation, declined. The authors suggest the liver’s own transport machinery may explain this selectivity, since hepatocytes actively take up tea polyphenols through organic anion-transporting polypeptides, concentrating the protective compounds where they are needed most.

Under the microscope, the damage and the rescue were both visible. Hematoxylin-eosin staining revealed that D-galactose had disrupted the architecture of hepatic lobules, disorganized hepatocytes, and loosened cytoplasm, abnormalities that tea treatment largely corrected. Masson staining, which dyes collagen blue, showed extensive fibrous proliferation in the aged livers that receded with treatment, and the fibrosis marker alpha-SMA fell in parallel at the protein level. Senescence itself left a measurable fingerprint: beta-galactosidase staining, a hallmark of senescent cells, lit up the D-galactose livers but faded with tea intervention. Western blotting completed the picture, showing that the senescence drivers P16, P21, and P53, which D-galactose had upregulated, were dialed back, while Sirt1, a longevity-associated deacetylase that D-galactose had suppressed, was restored.

To confirm the effect was not a rodent quirk, the team ran parallel experiments in cultured cells. They induced senescence in AML12 mouse hepatocytes and HepG2 human liver cancer cells using Nutlin-3a, a drug that activates p53-dependent senescence pathways. Co-treatment with the tea extract at one milligram per milliliter significantly reduced p16 and p21 protein levels in both cell lines and cut the fraction of blue-stained, senescence-positive cells. The consistency across mouse and human liver-derived cells strengthens the case that the anti-senescence activity is a genuine biological property of the extract rather than an artifact of one species or one model.

The mechanistic core of the study came from transcriptomics. Sequencing liver RNA revealed 1604 differentially expressed genes between D-galactose and control mice, and 3046 between D-galactose and high-dose tea mice, with 216 genes overlapping. Enrichment analyses converged on a single pathway: NF-κB, the master regulator of inflammatory transcription, was significantly activated by D-galactose and reversed by tea treatment. Gene set enrichment analysis confirmed the pattern, and western blots supplied the protein-level proof. D-galactose specifically increased the phosphorylation of the IKKα/β complex and of the p65 subunit, the molecular switch that releases NF-κB to enter the nucleus and ignite inflammatory gene expression. Tea extract suppressed both phosphorylation events in a dose-dependent fashion, while total protein levels stayed constant.

The authors frame this suppression as a direct counter to inflammaging, the chronic, low-grade inflammation that accompanies aging. Reactive oxygen species generated by dysfunctional mitochondria can activate the IKK complex through upstream kinases such as TAK1, and the tea’s restoration of antioxidant defenses likely starves that cascade of its trigger. The concurrent rise in Sirt1 adds a second brake, since Sirt1 can deacetylate p65 and dampen its transcriptional activity. The researchers are candid about limits: the D-galactose model captures oxidative stress-driven aging rather than the full complexity of natural senescence, and the cell experiments validated the phenotype rather than the upstream NF-κB axis, leaving causal validation for future work with naturally aged animals.

Even so, the translational arithmetic is tantalizing. The low mouse dose corresponds to about five grams of dry roasted Tieguanyin per day for a sixty-kilogram person, squarely within ordinary tea-drinking habits, while the high dose, equivalent to roughly twenty-five grams, could be reached through concentrated extracts or supplements. The authors envision the tea evolving from a traditional beverage into a functional food or anti-aging agent, pending clinical trials to confirm efficacy and optimal dosing in humans. For now, the study delivers something rarer than a health claim: a defined molecular pathway, verified at the levels of behavior, biochemistry, histology, transcriptome, and protein, through which a roasted oolong appears to slow the aging liver’s decline.

Subject of Research: Hepatoprotective and anti-senescence effects of roasted oolong tea extract in a D-galactose mouse aging model mediated by NF-κB pathway inhibition

Article Title: Protective Effects of Nongxiang‐Type Tieguanyin on the Liver of D‐Galactose‐Induced Aging C57BL/6 Mice via the NF‐κB Signaling Pathway

Article References: Chen, W., Li, M., Ye, L., Huang, D., Xiao, J., Sang, Y., Wang, Z., Yang, J., He, C., Chen, J., Zuo, Z., & Chen, X. (2026). Protective Effects of Nongxiang‐Type Tieguanyin on the Liver of D‐Galactose‐Induced Aging C57BL /6 Mice via the NF ‐ κB Signaling Pathway. Food Science & Nutrition, 14(10), Article e72396. https://doi.org/10.1002/fsn3.72396

Image Credits: AI Generated

DOI: 10.1002/fsn3.72396

Keywords: Tieguanyin, oolong tea, NF-κB signaling, liver aging, D-galactose, oxidative stress, cellular senescence, Sirt1, hepatic fibrosis, tea polyphenols, inflammaging, C57BL/6 mice